NCT03434912
Unknown
Not Applicable
Identification and Evaluation of the Potential Biomarkers on Circulating Tumor Cells and Tumor Related Rare Cells in Cancer Patients Undergoing Immunotherapy
ConditionsCTC and Tumor Related Rare Cell
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- CTC and Tumor Related Rare Cell
- Sponsor
- MiCareo Taiwan Co., Ltd.
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Circulating tumor cell
- Last Updated
- 7 years ago
Overview
Brief Summary
The primary objective of this study is designed to evaluate the enumeration of circulating tumor cells and identify the potential biomarkers associated with clinical outcome. The secondary objective is to explore whether the changes of tumor related rare cells associates clinical outcome.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Evidence of a personally signed and dated informed consent document indicating that the subject (or a legal representative) has been informed of all pertinent aspects of the study.
- •Over 20 years of age.
- •Cancer patients on immune checkpoint inhibitors.
Exclusion Criteria
- •Subjects who have other cancer history
- •Pregnant females
- •Subjects with active, known or suspected autoimmune disease.
- •Known history of human immunodeficiency virus (HIV)
Outcomes
Primary Outcomes
Circulating tumor cell
Time Frame: 1 years
Isolation and analysis of circulating tumor cells before and after immunotherapy
Secondary Outcomes
- tumor related rare cell(1 years)
Study Sites (1)
Loading locations...
Similar Trials
Not yet recruiting
Not Applicable
Identification and Characterization of Circulating Tumor Cells Before and After Treatment (Surgery and Radiotherapy) in a Cohort of Patients Treated for Resectable Stage I-III Merkel Cell CarcinomaMerkel Cell CarcinomaNCT06448611University Hospital, Montpellier25
Completed
Not Applicable
Circulating Tumor Cells in Solid TumorsSolid Tumor, AdultNCT03161821UNC Lineberger Comprehensive Cancer Center206
Completed
Not Applicable
Isolation of Circulating Tumor Cells Using a Novel EMT-Based Capture MethodMetastatic Progressive Castration-resistant Prostate CancerMetastatic Progressive Breast CancerNCT02025413Duke University46
Completed
Not Applicable
Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer PatientsLung CancerNCT00568282Stanford University219
Completed
Not Applicable
Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other CancersMelanomaNCT01528774Wolfram Samlowski150